In fact, miR-381-3p contributes to temozolomide resistance in glioblastoma cells by targeting NEFL and regulating stemness factors in an NEFL-dependent manner [150] (Figure 2 and Table 4). This evidence concerns the gene NEFL and glioblastoma.